Raymond Dalgleish studied Cell Biology at the University of Glasgow, graduating in 1976. His PhD concerned the molecular genetics of globin genes and was awarded in 1980 by St. Mary’s Hospital Medical School, University of London. Subsequently, he was a Fogarty International Research Fellow at the National Institutes of Health, Bethesda, Maryland, USA, cloning and analysing the first human collagen genes.
In 1984 he was appointed to a lectureship in the Department of Genetics and Genome Biology, University of Leicester, UK, where he is now Professor of Human Genetics. Raymond’s research has focused on the analysis of genes important in causing the heritable connective tissue disorders osteogenesis imperfecta (OI) and Ehlers-Danlos syndrome (EDS). His databases of OI and EDS gene sequence variants are widely used in clinical diagnostic testing.
Raymond is a member of the HGVS Sequence Variant Description Working Group. He is a member of the Council of the Human Genome Variation Society, a voting member of the International Scientific Committee of the Human Variome Project, and a member of the Clinical and Scientific Board of the Ehlers Danlos Society. His current principal project is the web-based VariantValidator tool (https://variantvalidator.org/) which helps ensure that sequence variant descriptions are compliant with the HGVS Sequence Variant Nomenclature.